Request a FREE Sample of our FcRn Binding Kit!Request a FREE Sample of our FcRn Binding Kit!
Limited Edition Golden Llama is here! Check out how you can get one. Limited Edition Golden Llama is here! Check out how you can get one.
Request a FREE sample of our GMP products! Request a FREE sample of our GMP products!
Cat. No. | Species | Product Description | Structure | Purity | Feature |
---|---|---|---|---|---|
ILA-H5214 | Human | Human IL-1 alpha / IL-1F1 Protein, premium grade |
|
|
|
ILA-M82E8 | Mouse | Biotinylated Mouse IL-1 alpha / IL-1F1 Protein, His,Avitag™ (MALS verified) |
|
||
ILA-H82E7 | Human | Biotinylated Human IL-1 alpha / IL-1F1 Protein, His,Avitag™ (MALS verified) |
|
|
|
ILA-M5213 | Mouse | Mouse IL-1 alpha / IL-1F1 Protein, His Tag (MALS verified) |
|
||
ILA-H5216 | Human | Human IL-1 alpha / IL-1F1 Protein, His Tag (MALS verified) |
|
|
Human IL-1 RII, Fc Tag (Cat. No. IL2-H4256) immobilized on CM5 Chip can bind Human IL-1 alpha Protein, premium grade (Cat. No. ILA-H5214) with an affinity constant of 18.8 μM as determined in a SPR assay (Biacore 8K) (QC tested).
Name | Research Code | Research Phase | Company | First Brand Name | First Approved Country | First Indication | First Approved Company | First Approved Date | Indications | Clinical Trials |
---|---|---|---|---|---|---|---|---|---|---|
Rilonacept | RGN-303; KPL-914 | Approved | Arcalyst | United States | Cryopyrin-Associated Periodic Syndromes | Kiniksa Pharmaceuticals Ltd | 2008-02-27 | Pericarditis; Inflammation; Scleroderma, Diffuse; Renal Insufficiency, Chronic; Gout; Urticaria; Cryopyrin-Associated Periodic Syndromes; Hearing Loss, Sensorineural; Genetic Diseases, Inborn; Diabetes Mellitus, Type 1; Arthritis, Juvenile; Deficiency of interleukin-1 receptor antagonist; Scleroderma, Systemic; Muckle-Wells Syndrome (MWS); Anemia; Schnitzler Syndrome; Familial Mediterranean Fever; Still's Disease, Adult-Onset | Details |
Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
---|---|---|---|---|---|
Tadekinig alfa (AB2 Bio) | Phase 3 Clinical | Ab2 Bio Ltd | Macrophage Activation Syndrome; Cytokine Release Syndrome; Lymphohistiocytosis, Hemophagocytic | Details | |
Bermekimab | T2-18C3; RA-18C3; CV-18C3; CA-18C3; MABP-1; MABp1; JNJ-77474462; MAB-p1 | Phase 2 Clinical | Xbiotech Inc | Acne Vulgaris; Hematologic Neoplasms; Pyoderma Gangrenosum; Digestive System Diseases; Diabetes Mellitus, Type 2; Neoplasms; Scleroderma, Systemic; Psoriasis; Colorectal Neoplasms; Hidradenitis Suppurativa; Eczema; Dermatitis, Atopic | Details |
lutikizumab | ABT-981 | Phase 2 Clinical | Abbvie Inc | Osteoarthritis, Knee; Colitis, Ulcerative; Hidradenitis Suppurativa; Osteoarthritis | Details |
AC-701 | AC-701 | Phase 2 Clinical | Twi Pharmaceuticals Inc | Rosacea; Exanthema | Details |
Vilamakitug | XB-2001 | Phase 2 Clinical | Xbiotech Inc | Pancreatic Neoplasms; Arthritis, Rheumatoid; Rheumatic Diseases | Details |
CAN-10 | CAN-10 | Phase 1 Clinical | Lund University Foundation | Scleroderma, Systemic; Psoriasis; Myocarditis; Plaque psoriasis | Details |
Hutrukin | Phase 1 Clinical | Xbiotech Inc | Details |
This web search service is supported by Google Inc.